Paramjit Grover
Overview
Explore the profile of Paramjit Grover including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prabhakar P, Reddy U, Singh S, Balasubramanyam A, Rahman M, Kumari S, et al.
J Appl Toxicol
. 2022 Nov;
43(4):615.
PMID: 36385386
No abstract available.
2.
Chinde S, Poornachandra Y, Panyala A, Kumari S, Yerramsetty S, Adicherla H, et al.
J Appl Toxicol
. 2022 Oct;
42(12):2045.
PMID: 36279886
No abstract available.
3.
Kumari M, Kumari S, Kamal S, Grover P
Mutat Res Genet Toxicol Environ Mutagen
. 2022 Aug;
881:503515.
PMID: 36031331
No abstract available.
4.
Panyala A, Chinde S, Kumari S, Grover P
J Appl Toxicol
. 2022 May;
42(6):1091-1093.
PMID: 35576186
No abstract available.
5.
Govindaiah P, Dumala N, Mattan I, Grover P, Jaya Prakash M
Bioorg Chem
. 2019 Aug;
91:103143.
PMID: 31374528
Coumarin-based different series of hydrazone derivatives were synthesized and evaluated for anticancer activity against four different human cancer cell lines. The activity of the compounds were compared with doxorubicin as...
6.
Govindaiah P, Dumala N, Grover P, Jaya Prakash M
Bioorg Med Chem Lett
. 2019 May;
29(14):1819-1824.
PMID: 31104996
A series of novel 4,7-dihydroxycoumarin based acryloylcyanohydrazone derivatives were synthesized and evaluated for antiproliferative activity against four different cancer cell lines (A549, HeLa, SKNSH, and MCF7). Most of the compounds...
7.
Dumala N, Mangalampalli B, Kamal S, Grover P
J Appl Toxicol
. 2019 Mar;
39(7):1012-1029.
PMID: 30843265
Despite the increasing use of nickel oxide (NiO) nanoparticles (NPs), limited information is available on their toxicological effects. Health consequences of 28 days repeated oral exposure to NiO NPs have...
8.
Dumala N, Mangalampalli B, Grover P
J Appl Toxicol
. 2019 Feb;
39(7):955-965.
PMID: 30763980
The current study was intended to elucidate the cytotoxicity, genotoxicity ability of nickel oxide (NiO) nanoparticles (NPs) and assessment of preliminary mechanism of the toxicity. Characterization studies showed that NiO-NPs...
9.
Panyala A, Chinde S, Kumari S, Rahman M, Mahboob M, Kumar J, et al.
Mutagenesis
. 2019 Feb;
34(2):181-201.
PMID: 30753658
Despite their enormous advantages, nanoparticles (NPs) have elicited disquiet over their safety. Among the numerous NPs, yttrium oxide (Y2O3) NPs are utilised in many applications. However, knowledge about their toxicity...
10.
Boda S, Pishka V, Lakshmi P, Chinde S, Grover P
Chem Biodivers
. 2018 Apr;
15(6):e18000101.
PMID: 29660245
A series of novel ethyl 2,7-dimethyl-4-oxo-3-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]-4,5-dihydro-3H-pyrano[2,3-d]pyrimidine-6-carboxylate derivatives 7a - 7m were efficiently synthesized employing click chemistry approach and evaluated for in vitro cytotoxic activity against four tumor cell lines: A549...